𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome

✍ Scribed by Masafumi Kobayashi; Yuko Takahashi; Hiroyuki Yamashita; Hiroshi Kaneko; Akio Mimori


Publisher
Springer
Year
2010
Tongue
English
Weight
201 KB
Volume
21
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES